SARGRAMOSTIM for Pancreatic carcinoma metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 39 adverse event reports in the FDA FAERS database where SARGRAMOSTIM was used for Pancreatic carcinoma metastatic.

Most Reported Side Effects for SARGRAMOSTIM

Side Effect	Reports	%	Deaths	Hosp.
Off label use	98	16.5%	12	10
Pyrexia	76	12.8%	3	23
Pain	56	9.4%	2	1
Hospitalisation	31	5.2%	0	24
Death	30	5.1%	29	0
Hypotension	25	4.2%	3	18
Device related infection	23	3.9%	1	1
Cough	20	3.4%	1	4
Febrile neutropenia	20	3.4%	1	5
Disease progression	18	3.0%	9	1
Device related bacteraemia	17	2.9%	0	0
Fatigue	16	2.7%	1	8
Hypersensitivity	16	2.7%	0	4
Nausea	16	2.7%	3	2
Injection site erythema	14	2.4%	0	0